CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Open-market sale Director sold 77,302 shares at an average $0.55 ($42,540)
- 4 Shares withheld for taxes See Remarks gave up 1,714 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,632 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,545 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,714 shares (to pay taxes)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 8,032 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 7,534 shares (to pay taxes)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 21,094 shares (to pay taxes)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 8,032 shares (to pay taxes)
- 4 Grant or award See Remarks acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,108 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.40 ($27,922)
Page 10 of 33 · 648 filings